Related Experiment Video
Updated: Aug 2, 2026

Capsular Serotyping of Streptococcus pneumoniae Using the Quellung Reaction
Published on: February 24, 2014
Serotype specificity of vaccine-induced immunity to pertussis
1Department of Medical Microbiology, University Medical School, Manchester.
Abstract:
Two large epidemics of pertussis occurred in Britain during 1977-79 and 1981-83, following a decline in vaccine uptake in the mid-1970s. Serotype 1,3 predominated during both epidemics but serotypes 1,2 and 1,2,3 constituted 32% (243 of 769) of the isolates from unvaccinated children compared with only 10% (9 of 86) of the isolates from vaccinated children (p < 0.005). Whole-cell vaccines, although effective against infection with all serotypes, have a higher efficacy against serotypes 1,2 and 1,2,3 than against serotype 1,3. These data suggest that not only should acellular vaccines contain agglutinogens specific for each serotype but trials should demonstrate efficacy against all three serotypes.
Insights
Pertussis epidemics in Britain were linked to reduced vaccine uptake. Current vaccines show varied efficacy against different pertussis serotypes, highlighting the need for broader protection.
Area of Science:
- Immunology
- Epidemiology
- Vaccinology
Background:
- Pertussis (whooping cough) epidemics occurred in Britain in the late 1970s and early 1980s.
- These outbreaks followed a significant decline in pertussis vaccine uptake.
- Pertussis is caused by the bacterium *Bordetella pertussis*, which has multiple serotypes.
Purpose of the Study:
- To investigate the serotype distribution of *Bordetella pertussis* isolates during pertussis epidemics.
- To compare the effectiveness of whole-cell pertussis vaccines against different serotypes.
- To inform the development of future acellular pertussis vaccines.
Main Methods:
- Analysis of *Bordetella pertussis* isolates from pertussis cases in Britain during epidemic periods.
- Comparison of serotype prevalence in unvaccinated versus vaccinated children.
- Evaluation of whole-cell vaccine efficacy based on existing data regarding serotype-specific protection.
Main Results:
- Serotype 1,3 predominated during both major pertussis epidemics.
- Serotypes 1,2 and 1,2,3 were significantly more prevalent in unvaccinated children (32%) compared to vaccinated children (10%).
- Whole-cell vaccines demonstrated higher efficacy against serotypes 1,2 and 1,2,3 than against serotype 1,3.
Conclusions:
- Pertussis vaccine effectiveness varies by serotype, with whole-cell vaccines being less protective against serotype 1,3.
- Future acellular pertussis vaccines should include antigens for all prevalent serotypes.
- Clinical trials must demonstrate efficacy against all three major pertussis serotypes to ensure comprehensive protection.
Related Concept Videos
Cross-reactivity
Vaccinations
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...
Active versus Passive Immunity
Active Immunity
Active immunity refers to the resistance one develops...
Vaccines
Poliomyelitis

